Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
424studies shown
Showing 361-372 of 424
Behavioral study icon
RecruitingNCT07119268

SPARK Healthy Sleep

This summary needs review. Please check the official study record and contact the research team for details.

In Indianapolis
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Indiana University
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT06831877

Study on Deep Transcranial Magnetic Stimulation for Enhancing Insight

This summary needs review. Please check the official study record and contact the research team for details.

In Shanghai
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 15 Years to 35 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Schizophrenia
Drug study icon
RecruitingNCT07680946

Safety study of safety and Efficacy of Ublituximab in schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
United States
Sponsor
TG Therapeutics, Inc.
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT03995121

SV2 PET Imaging With [11C]APP311

This summary needs review. Please check the official study record and contact the research team for details.

In New Haven
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, AddictionBehavioralFrom 18 Years to 85 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia, Addiction
Device study icon
RecruitingNCT04300946

Time Prediction and Cerebellum: Magnetic Transcranial Stimulation (TMS) in Healthy Volunteers

This summary needs review. Please check the official study record and contact the research team for details.

In Strasbourg
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 60 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia
Drug study icon
RecruitingISRCTN56047723

Transcranial alternating current stimulation for cognitive deficit in schizophrenia: effects and electrophysiological changes

This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In Czech Republic
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 70 Years
Countries
Czechia
Sponsor
National Institute of Mental Health
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT04639388

Understanding of Psychotic Disorders in Children With 22q11.2DS

This summary needs review. Please check the official study record and contact the research team for details.

In Lyon
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 4 Years to 13 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
Other study type icon
RecruitingNCT03332966

Youth Experiences and Health Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Oulu
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 15 Years to 18 Years
Countries
Finland
Sponsor
Finnish Institute for Health and Welfare
Condition
Schizophrenia
Drug study icon
RecruitingEUCTR 2022-000054-28

Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity (OligoTreat)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

Multiple locations, including Augsburg
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Germany
Sponsor
Klinikum der Universität München
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT06197048

Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Drammen
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaBehavioralOver 18 Years
Countries
Norway
Sponsor
Vestre Viken Hospital Trust
Condition
Bipolarity, Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.